IVA Stock Summary and Trading Ideas (Inventiva S.A. - American Depository Shares | NASDAQ:IVA)

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Inventiva S.A. - American Depository Shares trades on the NASDAQ stock market under the symbol IVA.

As of December 19, 2025, IVA stock price climbed to $4.21 with 260,850 million shares trading.

IVA has a beta of 0.30, meaning it tends to be less sensitive to market movements. IVA has a correlation of 0.00 to the broad based SPY ETF.

IVA has a market cap of $804.19 million. This is considered a Small Cap stock.

Last quarter Inventiva S.A. - American Depository Shares reported $5 million in Revenue and -$1.84 earnings per share. This fell short of revenue expectation by $-260,000 and missed earnings estimates by -$1.43.

In the last 3 years, IVA traded as high as $7.98 and as low as $1.53.

IVA has outperformed the market in the last year with a price return of +77.6% while the SPY ETF gained +18.1%. However, in the short term, IVA had mixed performance relative to the market. It has underperformed in the last 3 months, returning -25.5% vs +2.8% return in SPY. But in the last 2 weeks, IVA shares have fared better than the market returning +1.9% compared to SPY -0.5%.

IVA support price is $3.99 and resistance is $4.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVA shares will trade within this expected range on the day.